Hypoxenum - analogs
Components: Polydihydroxyphenylenethiosulfonate sodium |
|||||||||
Pharmgroups: Antihypoxants and antioxidants |
|||||||||
Prices in pharmacies: 6.8-8.7€ Instructions Hypoxenum | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Hypoxen solution for injections | — |
≈100% | Hypoxeni tablets | — |
≈100% | Olyphenum | — |
≈100% | Oliphen tablets | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 47% — Oxygenum [Oxygen]
- 42% 1.6-3.7€ Kudesan [Ubidecarenone]
- 41% 2-12.9€ Neurox [Ethylmethylhydroxypyridine succinate]
- 41% 1.6-3.9€ Medomexi [Ethylmethylhydroxypyridine succinate]
- 41% 1.6-2.3€ Cerecard [Ethylmethylhydroxypyridine succinate]
- 41% — Neurocard [Ethylmethylhydroxypyridine succinate]
- 41% — Проинин [Ethylmethylhydroxypyridine succinate]
- 40% 17-18.9€ Cytochrome C [Cytochrome C]
- 40% 2.8-3.4€ ЦИТОРЕАН [Ethylmethylhydroxypyridine succinate]
- 40% — Армадин лонг [Ethylmethylhydroxypyridine succinate]
- 38% — Elcar solution [Levocarnitine]
- 38% 3.7-15.7€ Evrin [Ethylmethylhydroxypyridine succinate]
- 38% 2.7-4.1€ МетуцинВел [Ethylmethylhydroxypyridine succinate]
- 37% 2.8-7.9€ Elcar [Levocarnitine]
- 37% — Mexidant [Ethylmethylhydroxypyridine succinate]
- 35% 0.7-7.9€ Mexicor [Ethylmethylhydroxypyridine succinate]
- 35% — Kudevite [Ubidecarenone and more 1Silicium dioxide colloidal]
- 32% 1.6-5.4€ Dihydroquercitin [Dihydroquercetin]
- 31% 3.1-9€ Mexidol [Ethylmethylhydroxypyridine succinate]
- 31% 2.4-3.8€ Нейромексол [Ethylmethylhydroxypyridine succinate]
- 31% — Ethylmethylhydroxypyridine succinate [Ethylmethylhydroxypyridine succinate]
- 31% — 3-hydroxy-6-methyl-2-ethylpyridine succinate [Ethylmethylhydroxypyridine succinate]
- 31% — Мексидолин-Ферейн [Ethylmethylhydroxypyridine succinate]
- 30% 1.1-2.1€ Ethylmethylhydroxypyridine-Akrihin [Ethylmethylhydroxypyridine succinate]
- 28% 2.7-4€ Dimephosphon [Dimethyloxobutylphosphonylmethylate]
- 28% — Aztreobol [Aztreonam]
- 27% — МЕКСэллара [Ethylmethylhydroxypyridine succinate]
- 27% — Мекситерра [Ethylmethylhydroxypyridine succinate]
- 27% — Мексипровел [Ethylmethylhydroxypyridine succinate]
- 27% — Spirosine [Cefotaxime]
- 27% — Мексидониум [Ethylmethylhydroxypyridine succinate]
- 27% — Наномексил [Ethylmethylhydroxypyridine succinate]
- 27% — Tirotax [Cefotaxime]
- 27% 1.9-3.1€ Акримекс [Ethylmethylhydroxypyridine succinate]
- 26% 0.2-11.2€ Cefotaxime [Cefotaxime]
- 26% — Cefotaxime sodium [Cefotaxime]
- 26% — Clafotaxim [Cefotaxime]
- 26% — Valeocor-Q10 [Ubidecarenone]
- 26% — Цефотаксим натрия - Лонг Шенг Фарма Лимитед [Cefotaxime]
- 26% — Tax-O-Bid [Cefotaxime]
- 26% — Cefotaxime-Promed [Cefotaxime]
- 26% — Цефотаксим натрия [Cefotaxime]
- 26% — Cefotaxime sodium sterile [Cefotaxime]
- 25% — Cefotaxime-Vial [Cefotaxime]
- 25% — Carnifit [Levocarnitine]
- 25% 0.3€ Cefazolin-AKOS [Cefazolin]
- 25% — Mexipridol [Ethylmethylhydroxypyridine succinate]
- 25% 2.8-22.7€ Licopid [Glucoseminyl muramildipeptide]
- 25% 0.2-0.7€ Cefazolin [Cefazolin]
- 25% — Tarcefoksym [Cefotaxime]
Learn more about the selection of analogues
- The drug has «Hypoxenum» 5 full analogs, for example Полидигидроксифенилентиосульфонат натрия; 51 analog by action, the most similar - Kudesan (1.6-3.7€).
- Medical online service has selected the best substitutes for Hypoxenum based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Hypoxenum analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.